|
⚲
|
| Keyboard |
| Lovenberg Walter M PhD
✚
|
|
|---|---|
| CIK # | 0001213100 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001213100] | |
| 4 | [0001213100] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lovenberg Walter M PhD | |
| Merrimack Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2012-04-25 | Option exercise | 5,462 | $2.19 | 11,962 |
|
Merrimack Pharmaceuticals Inc MACK
Stock Option (right to buy) · derivative
|
2012-04-25 | Option exercise | 5,462 | $0.00 | |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2012-04-03 | Conversion | 7,143 | ||
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2012-04-03 | Buy | 1,428 | $7.00 | 9,996 |
|
Merrimack Pharmaceuticals Inc MACK
Series D Convertible Preferred Stock · derivative
|
2012-04-03 | Conversion | 7,143 | $0.00 |